Resource Central is a product of the Pediatric Pandemic Network.

Nirsevimab Library

191200 of over 700 results

Applied Filters:

Building an Effective System of Care to Address Emerging Threats to Infants and Children
2024 · American Academy of Pediatrics (AAP), · Centers for Disease Control and Prevention (CDC)
The page describes a project by the American Academy of Pediatrics and the CDC to help pediatricians deal with new health threats to children, like …
Emergency Information Form for Children With Special Health Care Needs (EIF)
2022 · American Academy of Pediatrics (AAP), · American College of Emergency Physicians
The American College of Emergency Physicians and the American Academy of Pediatrics have introduced the Emergency Information Form (EIF) to ensure timely and appropriate care …
Preventing Hypothermia
2024 · Centers for Disease Control and Prevention (CDC)
This webpage explains how to prevent and treat hypothermia and frostbite during cold weather. It explains that hypothermia occurs when the body loses heat faster …
Wildfires and Children's Health Resources
2025 · National Institutes of Health (NIH)
This webpage provides resources to help protect children's health during wildfires. It describes how wildfires affect children and offers tips for families, communities, and healthcare …
Wildfires: What Parents Need to Know
2025 · Healthy Children
This webpage offers crucial information for parents on dealing with wildfires. It covers topics such as creating a family disaster plan, preparing a disaster supplies …
Veterans Health Library: Nirsevimab-alip
2025 · American Society of Health-System Pharmacists (ASHP), · U.S. Department of Veterans Affairs
This webpage provides drug information for Nirsevimab-alip (Brand Name: Beyfortus®). It addresses why and how it is used, special precautions, dietary instructions, and side effects.
MedlinePlus: Nirsevimab-alip
2024 · American Society of Health-System Pharmacists (ASHP), · U.S. Department of Health and Human Services (HHS)
This webpage provides drug information on nirsevimab-alip (brand name: Beyfortus®). It addresses why and how it should be used, special precautions, and side effects.
Drug Trials Snapshots: BEYFORTUS
2024 · U.S. Food and Drug Administration
This webpage features a drug trial snapshot for the drug Beyfortus, a monoclonal antibody given as an injection to protect against RSV. Snapshots reveal participants …
ACIP Evidence to Recommendations for Use of Nirsevimab in Children 8–19 Months of Age at Increased Risk of Severe Disease Entering Their Second RSV Season
2024 · Centers for Disease Control and Prevention (CDC)
This webpage provides evidence for the recommendations made by the Advisory Committee on Immunization Practices (ACIP) for the use of nirsevimab for a population of …
WHO Guidance for Business Continuity Planning
2018 · World Health Organization (WHO)
The WHO guidance for business continuity planning helps prepare for emergencies like pandemics. It describes how WHO can keep running during crises by identifying key …

Looking for different way to find resources?

Our chatbot aRCie can help with a more personalized search. Click below to try our new chatbot.

Try aRCie
191200 of over 700 results